Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells

Biological Psychiatry

Volumn 75, Issue 12, 2014, Pages 936-944

  Brennand, Kristen J ^a   Landek Salgado, Melissa A ^b   Sawa, Akira ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical heterogeneity; genetics; human induced pluripotent stem cells; mouse model; neuronal differentiation; schizophrenia

Indexed keywords

CELL SURFACE MARKER;

CELL HETEROGENEITY; DISEASE MODEL; FIBROBLAST; GENETIC VARIABILITY; HUMAN; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; REVIEW; SCHIZOPHRENIA; SOMATIC CELL; BIOLOGICAL MODEL; CELL DIFFERENTIATION; GENETICS; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, NEUROLOGICAL; NEURONS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 84901313139     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.10.025     Document Type: Review

References (102)

1. A. Sawa, and S.H. Snyder Schizophrenia: Diverse approaches to a complex disease Science 296 2002 692 695
2. D.R. Weinberger Implications of normal brain development for the pathogenesis of schizophrenia Arch Gen Psychiatry 44 1987 660 669
3. O. Marin Interneuron dysfunction in psychiatric disorders Nat Rev Neurosci 13 2012 107 120
4. G.K. Thaker, and W.T. Carpenter Jr Advances in schizophrenia Nat Med 7 2001 667 671
5. J. van Os, and S. Kapur Schizophrenia Lancet 374 2009 635 645
6. S.Z. Levine, I. Lurie, R. Kohn, and I. Levav Trajectories of the course of schizophrenia: From progressive deterioration to amelioration over three decades Schizophr Res 126 2011 184 191
7. M. Albus Clinical courses of schizophrenia Pharmacopsychiatry 45 suppl 1 2012 S31 S35
8. R. Schennach, S. Meyer, F. Seemuller, M. Jager, M. Schmauss, and G. Laux et al. Response trajectories in "real-world" naturalistically treated schizophrenia patients Schizophr Res 139 2012 218 224
9. R.R. Conley, and R.W. Buchanan Evaluation of treatment-resistant schizophrenia Schizophr Bull 23 1997 663 674
10. D.G. Robinson, M.G. Woerner, M. McMeniman, A. Mendelowitz, and R.M. Bilder Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder Am J Psychiatry 161 2004 473 479
11. R. Emsley, B. Chiliza, L. Asmal, and K. Lehloenya The concepts of remission and recovery in schizophrenia Curr Opin Psychiatry 24 2011 114 121
12. P.F. Sullivan, K.S. Kendler, and M.C. Neale Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies Arch Gen Psychiatry 60 2003 1187 1192
13. S.M. Purcell, N.R. Wray, J.L. Stone, P.M. Visscher, M.C. O'Donovan, and P.F. Sullivan et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder Nature 460 2009 748 752
14. T. Walsh, J.M. McClellan, S.E. McCarthy, A.M. Addington, S.B. Pierce, and G.M. Cooper et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia Science 320 2008 539 543
15. S. Gulsuner, T. Walsh, A.C. Watts, M.K. Lee, A.M. Thornton, and S. Casadei et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network Cell 154 2013 518 529
16. H. Jaaro-Peled, Y. Ayhan, M.V. Pletnikov, and A. Sawa Review of pathological hallmarks of schizophrenia: Comparison of genetic models with patients and nongenetic models Schizophr Bull 36 2010 301 313
17. P.J. Harrison The neuropathology of schizophrenia. A critical review of the data and their interpretation Brain 122 1999 593 624
18. Z. Sarnyai, M. Alsaif, S. Bahn, A. Ernst, P.C. Guest, and E. Hradetzky et al. Behavioral and molecular biomarkers in translational animal models for neuropsychiatric disorders Int Rev Neurobiol 101 2011 203 238
19. J. Chen, B.K. Lipska, and D.R. Weinberger Genetic mouse models of schizophrenia: From hypothesis-based to susceptibility gene-based models Biol Psychiatry 59 2006 1180 1188
20. D.B. Campbell, P.J. Ebert, T. Skelly, T.S. Stroup, J. Lieberman, and P. Levitt et al. Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia Biol Psychiatry 63 2008 32 41
21. P. Ferentinos, and D. Dikeos Genetic correlates of medical comorbidity associated with schizophrenia and treatment with antipsychotics Curr Opin Psychiatry 25 2012 381 390
22. J.L. McClay, D.E. Adkins, K. Aberg, S. Stroup, D.O. Perkins, and V.I. Vladimirov et al. Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics Mol Psychiatry 16 2011 76 85
23. V.K. Ota, L.N. Spindola, A. Gadelha, A.F. dos Santos Filho, M.L. Santoro, and D.M. Christofolini et al. DRD1 rs4532 polymorphism: A potential pharmacogenomic marker for treatment response to antipsychotic drugs Schizophr Res 142 2012 206 208
24. A. Hasan, A. Mitchell, A. Schneider, T. Halene, and S. Akbarian Epigenetic dysregulation in schizophrenia: Molecular and clinical aspects of histone deacetylase inhibitors Eur Arch Psychiatry Clin Neurosci 263 2013 273 284
25. S. Akbarian Epigenetics of schizophrenia Curr Top Behav Neurosci 4 2010 611 628
26. A.G. Cardno, and I.I. Gottesman Twin studies of schizophrenia: From bow-and-arrow concordances to star wars Mx and functional genomics Am J Med Genet 97 2000 12 17
27. A.S. Brown The environment and susceptibility to schizophrenia Prog Neurobiol 93 2011 23 58
28. E.F. Torrey, J.J. Bartko, and R.H. Yolken Toxoplasma gondii and other risk factors for schizophrenia: An update Schizophr Bull 38 2012 642 647
29. M. Scherr, M. Hamann, D. Schwerthoffer, T. Frobose, R. Vukovich, and G. Pitschel-Walz et al. Environmental risk factors and their impact on the age of onset of schizophrenia: Comparing familial to non-familial schizophrenia Nord J Psychiatry 66 2012 107 114
30. C.M. Connor, A. Dincer, J. Straubhaar, J.R. Galler, I.B. Houston, and S. Akbarian Maternal immune activation alters behavior in adult offspring, with subtle changes in the cortical transcriptome and epigenome Schizophr Res 140 2012 175 184
31. G. Kannan, A. Sawa, and M.V. Pletnikov Mouse models of gene-environment interactions in schizophrenia Neurobiol Dis 57 2013 5 11
32. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
33. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, and K. Tomoda et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
34. J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, and S. Tian et al. Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
35. K.J. Brennand, A. Simone, J. Jou, C. Gelboin-Burkhart, N. Tran, and S. Sangar et al. Modelling schizophrenia using human induced pluripotent stem cells Nature 473 2011 221 225
36. M.C. Marchetto, C. Carromeu, A. Acab, D. Yu, G.W. Yeo, and Y. Mu et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells Cell 143 2010 527 539
37. H. Ban, N. Nishishita, N. Fusaki, T. Tabata, K. Saeki, and M. Shikamura et al. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors Proc Natl Acad Sci U S A 108 2011 14234 14239
38. K. Nishimura, M. Sano, M. Ohtaka, B. Furuta, Y. Umemura, and Y. Nakajima et al. Development of defective and persistent Sendai virus vector: A unique gene delivery/expression system ideal for cell reprogramming J Biol Chem 286 2011 4760 4771
39. K. Okita, T. Ichisaka, and S. Yamanaka Generation of germline-competent induced pluripotent stem cells Nature 448 2007 313 317
40. K. Okita, Y. Matsumura, Y. Sato, A. Okada, A. Morizane, and S. Okamoto et al. A more efficient method to generate integration-free human iPS cells Nat Methods 8 2011 409 412
41. M. Stadtfeld, M. Nagaya, J. Utikal, G. Weir, and K. Hochedlinger Induced pluripotent stem cells generated without viral integration Science 322 2008 945 949
42. L. Warren, P.D. Manos, T. Ahfeldt, Y.H. Loh, H. Li, and F. Lau et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA Cell Stem Cell 7 2010 618 630
43. T. Seki, S. Yuasa, and K. Fukuda Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus Nat Protoc 7 2012 718 728
44. S.M. Choi, H. Liu, P. Chaudhari, Y. Kim, L. Cheng, and J. Feng et al. Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells Blood 118 2011 1801 1805
45. D. Rajesh, S.J. Dickerson, J. Yu, M.E. Brown, J.A. Thomson, and N.J. Seay Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells Blood 118 2011 1797 1800
46. J. Yu, K.F. Chau, M.A. Vodyanik, J. Jiang, and Y. Jiang Efficient feeder-free episomal reprogramming with small molecules PLoS One 6 2011 e17557
47. L.C. Laurent, I. Ulitsky, I. Slavin, H. Tran, A. Schork, and R. Morey et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture Cell Stem Cell 8 2011 106 118
48. S.M. Hussein, N.N. Batada, S. Vuoristo, R.W. Ching, R. Autio, and E. Narva et al. Copy number variation and selection during reprogramming to pluripotency Nature 471 2011 58 62
49. J. Mariani, M.V. Simonini, D. Palejev, L. Tomasini, G. Coppola, and A.M. Szekely et al. Modeling human cortical development in vitro using induced pluripotent stem cells Proc Natl Acad Sci U S A 109 2012 12770 12775
50. Y. Shi, P. Kirwan, J. Smith, H.P. Robinson, and F.J. Livesey Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses Nat Neurosci 15 477-486 2012 S471
51. C.R. Nicholas, J. Chen, Y. Tang, D.G. Southwell, N. Chalmers, and D. Vogt et al. Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development Cell Stem Cell 12 2013 573 586
52. A.M. Maroof, S. Keros, J.A. Tyson, S.W. Ying, Y.M. Ganat, and F.T. Merkle et al. Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells Cell Stem Cell 12 2013 559 572
53. S.M. Chambers, C.A. Fasano, E.P. Papapetrou, M. Tomishima, M. Sadelain, and L. Studer Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling Nat Biotechnol 27 2009 275 280
54. S. Kriks, J.W. Shim, J. Piao, Y.M. Ganat, D.R. Wakeman, and Z. Xie et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease Nature 480 2011 547 551
55. J.E. Kim, M.L. O'Sullivan, C.A. Sanchez, M. Hwang, M.A. Israel, and K. Brennand et al. Investigating synapse formation and function using human pluripotent stem cell-derived neurons Proc Natl Acad Sci U S A 108 2011 3005 3010
56. S.H. Yuan, J. Martin, J. Elia, J. Flippin, R.I. Paramban, and M.P. Hefferan et al. Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells PLoS One 6 2011 e17540
57. Z.P. Pang, N. Yang, T. Vierbuchen, A. Ostermeier, D.R. Fuentes, and T.Q. Yang et al. Induction of human neuronal cells by defined transcription factors Nature 476 2011 220 223
58. R. Ambasudhan, M. Talantova, R. Coleman, X. Yuan, S. Zhu, and S.A. Lipton et al. Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions Cell Stem Cell 9 2011 113 118
59. A.S. Yoo, A.X. Sun, L. Li, A. Shcheglovitov, T. Portmann, and Y. Li et al. MicroRNA-mediated conversion of human fibroblasts to neurons Nature 476 2011 228 231
60. M. Caiazzo, M.T. Dell'Anno, E. Dvoretskova, D. Lazarevic, S. Taverna, and D. Leo et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts Nature 476 2011 224 227
61. J. Kim, S.C. Su, H. Wang, A.W. Cheng, J.P. Cassady, and M.A. Lodato et al. Functional integration of dopaminergic neurons directly converted from mouse fibroblasts Cell Stem Cell 9 2011 413 419
62. Y. Zhang, C. Pak, Y. Han, H. Ahlenius, Z. Zhang, and S. Chanda et al. Rapid single-step induction of functional neurons from human pluripotent stem cells Neuron 78 2013 785 798
63. E. Lujan, S. Chanda, H. Ahlenius, T.C. Sudhof, and M. Wernig Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells Proc Natl Acad Sci U S A 109 2012 2527 2532
64. C. Tian, R.J. Ambroz, L. Sun, Y. Wang, K. Ma, and Q. Chen et al. Direct conversion of dermal fibroblasts into neural progenitor cells by a novel cocktail of defined factors Curr Mol Med 12 2012 126 137
65. K.L. Ring, L.M. Tong, M.E. Balestra, R. Javier, Y. Andrews-Zwilling, and G. Li et al. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor Cell Stem Cell 11 2012 100 109
66. I. Espuny-Camacho, K.A. Michelsen, D. Gall, D. Linaro, A. Hasche, and J. Bonnefont et al. Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo Neuron 77 2013 440 456
67. B.Y. Hu, Z.W. Du, and S.C. Zhang Differentiation of human oligodendrocytes from pluripotent stem cells Nat Protoc 4 2009 1614 1622
68. S. Wang, J. Bates, X. Li, S. Schanz, D. Chandler-Militello, and C. Levine et al. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination Cell Stem Cell 12 2013 252 264
69. R. Freedman, H. Coon, M. Myles-Worsley, A. Orr-Urtreger, A. Olincy, and A. Davis et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus Proc Natl Acad Sci U S A 94 1997 587 592
70. M.A. Geyer, N.R. Swerdlow, R.S. Mansbach, and D.L. Braff Startle response models of sensorimotor gating and habituation deficits in schizophrenia Brain Res Bull 25 1990 485 498
71. A.D. Radant, K. Claypoole, D.K. Wingerson, D.S. Cowley, and P.P. Roy-Byrne Relationships between neuropsychological and oculomotor measures in schizophrenia patients and normal controls Biol Psychiatry 42 1997 797 805
72. T.A. Greenwood, G.A. Light, N.R. Swerdlow, A.D. Radant, and D.L. Braff Association analysis of 94 candidate genes and schizophrenia-related endophenotypes PLoS One 7 2012 e29630
73. M.J. McCarthy, S.G. Leckband, and J.R. Kelsoe Pharmacogenetics of lithium response in bipolar disorder Pharmacogenomics 11 2010 1439 1465
74. K.S. Kendler What psychiatric genetics has taught us about the nature of psychiatric illness and what is left to learn Mol Psychiatry 18 2013 1058 1066
75. A. Berndt, P. Schoenenberger, J. Mattis, K.M. Tye, K. Deisseroth, and P. Hegemann et al. High-efficiency channelrhodopsins for fast neuronal stimulation at low light levels Proc Natl Acad Sci U S A 108 2011 7595 7600
76. L.A. Gunaydin, O. Yizhar, A. Berndt, V.S. Sohal, K. Deisseroth, and P. Hegemann Ultrafast optogenetic control Nat Neurosci 13 2010 387 392
77. A. Muto, M. Ohkura, T. Kotani, S. Higashijima, J. Nakai, and K. Kawakami Genetic visualization with an improved GCaMP calcium indicator reveals spatiotemporal activation of the spinal motor neurons in zebrafish Proc Natl Acad Sci U S A 108 2011 5425 5430
78. D. Malhotra, and J. Sebat CNVs: Harbingers of a rare variant revolution in psychiatric genetics Cell 148 2012 1223 1241
79. C.H. Chiang, Y. Su, Z. Wen, N. Yoritomo, C.A. Ross, and R.L. Margolis et al. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation Mol Psychiatry 16 2011 358 360
80. E.K. Green, N. Norton, T. Peirce, D. Grozeva, G. Kirov, and M.J. Owen et al. Evidence that a DISC1 frame-shift deletion associated with psychosis in a single family may not be a pathogenic mutation Mol Psychiatry 11 2006 798 799
81. E. Pedrosa, V. Sandler, A. Shah, R. Carroll, C. Chang, and S. Rockowitz et al. Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells J Neurogenet 25 2011 88 103
82. I. Splawski, K.W. Timothy, L.M. Sharpe, N. Decher, P. Kumar, and R. Bloise et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism Cell 119 2004 19 31
83. J.F. Krey, S.P. Pasca, A. Shcheglovitov, M. Yazawa, R. Schwemberger, and R. Rasmusson et al. Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons Nat Neurosci 16 2013 201 209
84. S.P. Pasca, T. Portmann, I. Voineagu, M. Yazawa, A. Shcheglovitov, and A.M. Pasca et al. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome Nat Med 17 2011 1657 1662
85. R.Z. Chen, S. Akbarian, M. Tudor, and R. Jaenisch Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice Nat Genet 27 2001 327 331
86. G. Ananiev, E.C. Williams, H. Li, and Q. Chang Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model PLoS One 6 2011 e25255
87. A.Y. Cheung, L.M. Horvath, D. Grafodatskaya, P. Pasceri, R. Weksberg, and A. Hotta et al. Isolation of MECP2-null Rett syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation Hum Mol Genet 20 2011 2103 2115
88. N. Farra, W.B. Zhang, P. Pasceri, J.H. Eubanks, M.W. Salter, and J. Ellis Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations Mol Psychiatry 17 2012 1261 1271
89. R.G. Steen, C. Mull, R. McClure, R.M. Hamer, and J.A. Lieberman Brain volume in first-episode schizophrenia: Systematic review and meta-analysis of magnetic resonance imaging studies Br J Psychiatry 188 2006 510 518
90. A. Vita, L. De Peri, C. Silenzi, and M. Dieci Brain morphology in first-episode schizophrenia: A meta-analysis of quantitative magnetic resonance imaging studies Schizophr Res 82 2006 75 88
91. I.C. Wright, S. Rabe-Hesketh, P.W. Woodruff, A.S. David, R.M. Murray, and E.T. Bullmore Meta-analysis of regional brain volumes in schizophrenia Am J Psychiatry 157 2000 16 25
92. N.S. Kolomeets, D.D. Orlovskaya, V.I. Rachmanova, and N.A. Uranova Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: A postmortem morphometric study Synapse 57 2005 47 55
93. G. Rajkowska, L.D. Selemon, and P.S. Goldman-Rakic Neuronal and glial somal size in the prefrontal cortex: A postmortem morphometric study of schizophrenia and Huntington disease Arch Gen Psychiatry 55 1998 215 224
94. J.E. Black, I.M. Kodish, A.W. Grossman, A.Y. Klintsova, D. Orlovskaya, and V. Vostrikov et al. Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia Am J Psychiatry 161 2004 742 744
95. L.D. Selemon, and P.S. Goldman-Rakic The reduced neuropil hypothesis: A circuit based model of schizophrenia Biol Psychiatry 45 1999 17 25
96. L.A. Glantz, and D.A. Lewis Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia Arch Gen Psychiatry 57 2000 65 73
97. L.J. Garey, W.Y. Ong, T.S. Patel, M. Kanani, A. Davis, and A.M. Mortimer et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia J Neurol Neurosurg Psychiatry 65 1998 446 453
98. N.J. Brandon, and A. Sawa Linking neurodevelopmental and synaptic theories of mental illness through DISC1 Nat Rev Neurosci 12 2011 707 722
99. L. Mei, and W.C. Xiong Neuregulin 1 in neural development, synaptic plasticity and schizophrenia Nat Rev Neurosci 9 2008 437 452
100. B.D. Paulsen, R.D. Maciel, A. Galina, M.S. da Silveira, C.D. Souza, and H. Drummond et al. Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient Cell Transplant 21 2012 1547 1559
101. O. Robicsek, R. Karry, I. Petit, N. Salman-Kesner, F.J. Muller, and E. Klein et al. Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients Mol Psychiatry 18 2013 1067 1076
102. T. Insel, B. Cuthbert, M. Garvey, R. Heinssen, D.S. Pine, and K. Quinn et al. Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders Am J Psychiatry 167 2010 748 751